文献速递心律失常心力衰竭与心肌病

心房颤动:诊断年龄、新发心血管事件与死亡

Atrial fibrillation: age at diagnosis, incident cardiovascular events, and mortality.
PubMed 文献 · Eur Heart J · 2024-01-01

结果显示,≤50岁诊断房颤者后续心肌病、心衰、缺血性卒中和死亡的风险比更高,预期平均寿命损失9.2年,且估计值随年龄增长而降低。

要点

  • ≤50岁房颤患者心肌病风险比为8.90,心衰为8.64,缺血性卒中为2.18,死亡为2.74。
  • ≤50岁诊断房颤者预期平均寿命损失9.2年,风险估计随年龄增长而降低。
  • 研究提示较早诊断房颤与后续心肌疾病风险比更高和预期寿命更短相关。

核心结论

  • 较早诊断房颤与后续心肌疾病风险比更高和预期寿命更短相关。
  • 需进一步研究确定因果关系及房颤能否作为年轻患者的风险标志。

研究设计与样本

  • 采用基于性别、出生年和索引日期的暴露密度匹配,平均随访7.9年。
  • 按年龄组分层,使用竞争风险生存分析和Cox回归模型评估绝对风险与风险率。

主要发现

  • ≤50岁房颤患者与匹配对照相比,心肌病风险比为8.90(95%CI 7.17-11.0)。
  • ≤50岁房颤患者心衰风险比为8.64(95%CI 7.74-9.64),缺血性卒中风险比为2.18(95%CI 1.89-2.52)。
  • ≤50岁房颤患者死亡风险比为2.74(95%CI 2.53-2.96),预期平均寿命损失9.2年(95%CI 9.0-9.3)。
  • 上述估计值随年龄增长而降低。

临床怎么用

  • 对年轻房颤患者应关注后续心肌病、心衰、缺血性卒中和死亡风险。
  • 年轻房颤诊断可能提示需更密切的心血管风险评估与随访。

局限性

  • 研究为观察性设计,无法确定因果关系。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Patients with atrial fibrillation (AF) are at increased risks of cardiovascular diseases and mortality, but risks according to age at diagnosis have not been reported. This study investigated age-specific risks of outcomes among patients with AF and the background population. METHODS: This nationwide population-based cohort study included patients with AF and controls without outcomes by the application of exposure density matching on the basis of sex, year of birth, and index date. The absolute risks and hazard rates were stratified by age groups and assessed using competing risk survival analyses and Cox regression models, respectively. The expected differences in residual life years among participants were estimated. RESULTS: The study included 216 579 AF patients from year 2000 to 2020 and 866 316 controls. The mean follow-up time was 7.9 years. Comparing AF patients with matched controls, the hazard ratios among individuals ≤50 years was 8.90 [95% confidence interval (CI), 7.17-11.0] for cardiomyopathy, 8.64 (95% CI, 7.74-9.64) for heart failure, 2.18 (95% CI, 1.89-2.52) for ischaemic stroke, and 2.74 (95% CI, 2.53-2.96) for mortality. The expected average loss of life years among individuals ≤50 years was 9.2 years (95% CI, 9.0-9.3) years. The estimates decreased with older age. CONCLUSIONS: The findings show that earlier diagnosis of AF is associated with a higher hazard ratio of subsequent myocardial disease and shorter life expectancy. Further studies are needed to determine causality and whether AF could be used as a risk marker among particularly younger patients.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Paludan-Müller, Vad, Stampe, et al. Atrial fibrillation: age at diagnosis, incident cardiovascular events, and mortality. Eur Heart J. 2024. PMID: 38592444. doi:10.1093/eurheartj/ehae216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。